Biosimilars of low molecular weight heparins: Relevant background information for your drug formulary-Reference-Cited by-同舟云学术

Biosimilars of low molecular weight heparins: Relevant background information for your drug formulary

Published:2019-09-04 Issue:11 Volume:85 Page:2479-2486
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Brouwers Jacobus R.B.J.¹²^ORCID,Roeters van Lennep Jeanine E.³,Beinema Maarten J.⁴

Affiliation:

1. Unit Pharmacotherapy ‐Epidemiology and ‐Economy, Groningen Research Institute of PharmacyUniversity of Groningen Groningen The Netherlands

2. Expertise Centre Pharmacotherapy in Old Persons Oranjewoud The Netherlands

3. Department of Internal Medicine‐subdivision Vascular MedicineErasmus Medical Center Rotterdam The Netherlands

4. Anticoagualation CenterDeventer Hospital Deventer The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14081

Reference44 articles.

1. The story of the discovery of heparin and warfarin

2. A century of heparin: past, present and future

3. Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

4. Management of Venous Thromboembolism in Pregnancy

5. EMA‐Guideline on non‐clinical and clinical development of similar biological medicinal products containing low‐molecular‐weight‐ heparins 10 Nov 2016 EMA/CHMP/BMWP/118264/2007 revision 1(into effect 01‐June 2017) p1–8.https://www.ema.europa.eu/en/documents/scientific‐guideline/guideline‐non‐clinical‐clinical‐development‐similar‐biological‐medicinal‐products‐containing‐low_en.pdf. Accessed August 17 2019.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality control, safety assessment and preparation approaches of low molecular weight heparin;Carbohydrate Polymers;2024-09

2. A Descriptive Analysis of Direct Oral Anticoagulant Drugs Dosing Errors Based on Spontaneous Reports from the EudraVigilance Database;Pharmaceuticals;2023-03-17

3. Bioequivalence of a biosimilar enoxaparin ( Cloti‐Xa™ ) and its innovator (Clexane ^® ): A single‐dose , randomized, double‐blind , two‐period , two‐treatment , two‐sequence , crossover, balanced study in healthy human subjects;Pharmacology Research & Perspectives;2022-06-28

4. Essential medicine required for national SRHR guidelines implementation in Iraq;Journal Of Advanced Pharmacy Education And Research;2021